KIAA1524 Produits
(KIAA1524)
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories KIAA1524 en vedette
KIAA1524 Anticorps
High quality antibodies with extensive validation data.
KIAA1524 Kits ELISA
Reliable ELISA kits for a wide range of species.
KIAA1524 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
KIAA1524 recommandé Anticorps
- (2)
- (3)
- (1)
KIAA1524 recommandé Kits ELISA
- (1)
- (1)
KIAA1524 recommandé Protéines
Dernières publications sur nos produits KIAA1524
: "Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer." dans: Oncology letters, Vol. 17, Issue 1, pp. 1211-1216, (2019) (PubMed).: "DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury." dans: Oncotarget, Vol. 9, Issue 5, pp. 6402-6415, (2018) (PubMed).
: "CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells." dans: Journal of cellular and molecular medicine, Vol. 22, Issue 9, pp. 4150-4160, (2018) (PubMed).
: "ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer." dans: Molecular oncology, Vol. 12, Issue 10, pp. 1706-1717, (2018) (PubMed).
: "Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis." dans: American journal of translational research, Vol. 9, Issue 5, pp. 2327-2339, (2017) (PubMed).
: "CIP2A mediates prostate cancer progression via the c-MYC signaling pathway." dans: Tumour biology, Vol. 36, Issue 5, pp. 3583-9, (2015) (PubMed).
: "Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1." dans: Oncotarget, Vol. 6, Issue 7, pp. 5253-62, (2015) (PubMed).
: "Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma." dans: Cancer medicine, Vol. 4, Issue 6, pp. 903-13, (2015) (PubMed).
: "Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy." dans: BMC cancer, Vol. 15, pp. 301, (2015) (PubMed).
: "CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations." dans: Oncotarget, Vol. 6, Issue 23, pp. 19661-70, (2015) (PubMed).
Synonymes et noms alternatifs relatifs à KIAA1524
cell proliferation regulating inhibitor of protein phosphatase 2A (CIP2A), RIKEN cDNA C330027C09 gene (C330027C09Rik), KIAA1524 (KIAA1524), cell proliferation regulating inhibitor of protein phosphatase 2A L homeolog (cip2a.L), CONSTANS interacting protein 2a (CIP2a), cell proliferation regulating inhibitor of protein phosphatase 2A (cip2a), cell proliferation regulating inhibitor of protein phosphatase 2A (Cip2a), AA408511, AU018569, CIP2A, Cip2a, Kiaa1524, KIAA1524, LOC100222895, p90, RGD1310335Protein level used designations for KIAA1524
- cancerous inhibitor of PP2A
- p90 autoantigen
- protein CIP2A
- p90 autoantigen homolog
- protein CIP2A homolog
- KIAA1524
- CONSTANS interacting protein 2a
- hypothetical protein LOC100216050